Share：
Share this content in WeChat
X
[Chinese] [PDF] 52 1
• Case Report •
Myxoinflammatory fibroblastic sarcoma of the hip: One case report
PENG Yue  CHEN Qianqian  REN Tiezhu  MA Long  ZHANG Wenjuan 

Cite this article as: PENG Y, CHEN Q Q, REN T Z, et al. Myxoinflammatory fibroblastic sarcoma of the hip: One case report[J]. Chin J Magn Reson Imaging, 2025, 16(7): 88-90. DOI:10.12015/issn.1674-8034.2025.07.014.


[Keywords] hip；myxoinflammatory fibroblastic sarcoma；magnetic resonance imaging；differential diagnosis

PENG Yue1, 2, 3, 4   CHEN Qianqian1, 2, 3, 4   REN Tiezhu1, 2, 3, 4   MA Long1, 2, 3, 4   ZHANG Wenjuan1, 2, 3, 4*  

1 Department of Radiology, the Second Hospital of Lanzhou University, Lanzhou 730000, China

2 Second Clinical School of Lanzhou University, Lanzhou 730000, China

3 Key Laboratory of Medical Imaging of Gansu Province Lanzhou 730000, China

4 Gansu International Scientific and Technological Cooperation Base of Medical Imaging Artificial Intelligence, Lanzhou 730030, China

Corresponding author: ZHANG W J, E-mail: hxzhangwj121@163.com

Conflicts of interest   None.

Received  2025-01-10
Accepted  2025-05-10
DOI: 10.12015/issn.1674-8034.2025.07.014
Cite this article as: PENG Y, CHEN Q Q, REN T Z, et al. Myxoinflammatory fibroblastic sarcoma of the hip: One case report[J]. Chin J Magn Reson Imaging, 2025, 16(7): 88-90. DOI:10.12015/issn.1674-8034.2025.07.014.

[1]
WARDELMANN E, HARTMANN W. Neues in der aktuellen WHO-klassifikation (2020) für weichgewebssarkome[J]. Der Pathol, 2021, 42(3): 281-293. DOI: 10.1007/s00292-021-00935-8.
[2]
LUCAS D R. Myxoinflammatory fibroblastic sarcoma: review and update[J]. Arch Pathol Lab Med, 2017, 141(11): 1503-1507. DOI: 10.5858/arpa.2017-0219-RA.
[3]
LI Y Z, ZHANG L Y, HUO M Y, et al. Please diagnose case 166 answer: hepatic myxoinflammatory fibroblastic sarcoma with postoperative recurrence[J]. Radiol Pract, 2024, 39(9): 1276-1278. DOI: 10.13609/j.cnki.1000-0313.2024.09.029.
[4]
SHAN K K, WEN J Y, MA X L, et al. Hepatic myxoinflammatory fibroblastic sarcoma: a case report and literature review[J]. Asian J Surg, 2023, 46(10): 4444-4446. DOI: 10.1016/j.asjsur.2023.04.102.
[5]
NISHIO J, NAKAYAMA S, AOKI M. Recent advances in the diagnosis, pathogenesis, and management of myxoinflammatory fibroblastic sarcoma[J/OL]. Int J Mol Sci, 2024, 25(2): 1127 [2025-01-09]. https://pmc.ncbi.nlm.nih.gov/articles/PMC10816835/. DOI: 10.3390/ijms25021127.
[6]
PÉREZ-PÉREZ M, MANZOTTI C, MATEOS M M, et al. Myxoinflammatory fibroblastic sarcoma: a rare case affecting only the dermis[J]. J Cutan Pathol, 2020, 47(4): 414-415. DOI: 10.1111/cup.13638.
[7]
LI J, DING X D, FENG X D, et al. Mucinous inflammatory fibroblastic sarcoma: a clinicopathological analysis of 10 cases[J]. Chin J Clin Exp Pathol, 2016, 32(1): 88-90. DOI: 10.13315/j.cnki.cjcep.2016.01.020.
[8]
TATEISHI U, HASEGAWA T, ONAYA H, et al. Myxoinflammatory fibroblastic sarcoma: MR appearance and pathologic correlation[J]. AJR Am J Roentgenol, 2005, 184(6): 1749-1753. DOI: 10.2214/ajr.184.6.01841749.
[9]
BAHETI A D, TIRUMANI S H, ROSENTHAL M H, et al. Myxoid soft-tissue neoplasms: comprehensive update of the taxonomy and MRI features[J]. AJR Am J Roentgenol, 2015, 204(2): 374-385. DOI: 10.2214/AJR.14.12888.
[10]
QU G X, ZHANG C L, TIAN Z C, et al. Diagnosis and treatment of myxoid liposarcoma[J]. Curr Treat Options Oncol, 2024, 25(10): 1289-1296. DOI: 10.1007/s11864-024-01262-9.
[11]
GAETKE-UDAGER K, YABLON C M, LUCAS D R, et al. Myxoinflammatory fibroblastic sarcoma: spectrum of disease and imaging presentation[J]. Skeletal Radiol, 2016, 45(3): 347-356. DOI: 10.1007/s00256-015-2286-2.

PREV A case of anti-NMDAR encephalitis with bilateral basal ganglia symmetry lesions
NEXT Research progress in neuroimaging of autism spectrum disorder
  


LINK


Tel & Fax: +8610-67113815    E-mail: editor@cjmri.cn